{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:27:44Z","timestamp":1793755664550,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,18]],"date-time":"2027-09-18T00:00:00Z","timestamp":1821225600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA273349"],"award-info":[{"award-number":["R01 CA273349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA210240"],"award-info":[{"award-number":["U01 CA210240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA256973"],"award-info":[{"award-number":["R01 CA256973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA200466"],"award-info":[{"award-number":["U01 CA200466"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.gastro.2026.04.041","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:26:38Z","timestamp":1779719198000},"page":"717-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer"],"prefix":"10.1053","volume":"171","author":[{"given":"Namita","family":"Bhyravbhatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa W.","family":"Alsafwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwor","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palanisamy","family":"Nallasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita","family":"Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Moran Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Villalobos-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanakumar","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokenge","family":"Malafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Ghersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.04.041_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","article-title":"Mucins in pancreatic cancer and its microenvironment","volume":"10","author":"Kaur","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.041_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800445","article-title":"Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer","volume":"18","author":"Rakha","year":"2005","journal-title":"Modern Pathol"},{"key":"10.1053\/j.gastro.2026.04.041_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1053\/j.gastro.2026.04.041_bib4","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/gast.1996.v110.pm8613039","article-title":"Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis","volume":"110","author":"Bresalier","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.041_bib5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/1878-0261.12956","article-title":"ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation","volume":"15","author":"Lakshmanan","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1053\/j.gastro.2026.04.041_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41388-022-02587-1","article-title":"Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis","volume":"42","author":"Bhatia","year":"2023","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2026.04.041_bib7","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.18632\/oncotarget.3308","article-title":"Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells","volume":"6","author":"Das","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2026.04.041_bib8","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1158\/1538-7445.AM2020-6072","article-title":"MUC16-Cter cleavage increases the metastatic potential in pancreatic cancer","volume":"80","author":"Marimuthu","year":"2020","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-11","article-title":"MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells","volume":"9","author":"Gubbels","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2026.04.041_bib10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/j.gastro.2022.02.032","article-title":"Mucin 5AC\u2013mediated CD44\/ITGB1 clustering mobilizes adipose-derived mesenchymal stem cells to modulate pancreatic cancer stromal heterogeneity","volume":"162","author":"Ganguly","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.041_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-129","article-title":"MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress","volume":"13","author":"Felder","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1053\/j.gastro.2026.04.041_bib12","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1038\/sj.onc.1210532","article-title":"IFN-\u03b3-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-\u03b3 response","volume":"26","author":"Andrianifahanana","year":"2007","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2026.04.041_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","article-title":"et al. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia","volume":"25","author":"McAllister","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2026.04.041_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2007.10.009","article-title":"Cytokine regulation of mucin secretion in a human middle ear epithelial model","volume":"41","author":"Samuel","year":"2008","journal-title":"Cytokine"},{"key":"10.1053\/j.gastro.2026.04.041_bib15","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.18632\/oncotarget.7652","article-title":"Tumor necrosis factor-\u03b1 and interferon-\u03b3 stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NF\u03baB","volume":"7","author":"Morgado","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2026.04.041_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/0008-5472.CAN-20-1293","article-title":"Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness","volume":"81","author":"Ganguly","year":"2021","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib17","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/1541-7786.MCR-21-0888","article-title":"MUC16 promotes liver metastasis of pancreatic ductal adenocarcinoma by upregulating NRP2-associated cell adhesion","volume":"20","author":"Marimuthu","year":"2022","journal-title":"Mol Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/cancers2041794","article-title":"Mucins and pancreatic cancer","volume":"2","author":"Jonckheere","year":"2010","journal-title":"Cancers"},{"key":"10.1053\/j.gastro.2026.04.041_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1158\/1538-7445.AM2024-1594","article-title":"Pancreatic cancer and T-cell crosstalk-induced MUC4 expression attenuates T-cell-mediated response","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib20","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1038\/s41388-022-02493-6","article-title":"Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma","volume":"41","author":"Lakshmanan","year":"2022","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2026.04.041_bib21","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1158\/1078-0432.CCR-21-1591","article-title":"Mucin expression and splicing determine novel subtypes and patient mortality in pancreatic ductal adenocarcinoma","volume":"27","author":"Thompson","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.celrep.2017.03.037","article-title":"Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis","volume":"19","author":"Tsujikawa","year":"2017","journal-title":"Cell Rep"},{"key":"10.1053\/j.gastro.2026.04.041_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-020-00776-9","article-title":"Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions","volume":"12","author":"Lin","year":"2020","journal-title":"Genome Med"},{"key":"10.1053\/j.gastro.2026.04.041_bib25","doi-asserted-by":"crossref","first-page":"eabl4896","DOI":"10.1126\/science.abl4896","article-title":"The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans","volume":"376","author":"Tabula Sapiens","year":"2022","journal-title":"Science"},{"key":"10.1053\/j.gastro.2026.04.041_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","article-title":"Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis","volume":"16","author":"Kim","year":"2024","journal-title":"Genome Med"},{"key":"10.1053\/j.gastro.2026.04.041_bib27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2026.04.041_bib28","series-title":"Statistical methods for RNA sequencing data analysis","first-page":"85","author":"Li","year":"2019"},{"key":"10.1053\/j.gastro.2026.04.041_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2315509121","article-title":"The MUC1\u2013HIF-1\u03b1 signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling","volume":"121","author":"Murthy","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2026.04.041_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatology"},{"key":"10.1053\/j.gastro.2026.04.041_bib31","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ymthe.2020.12.029","article-title":"Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer","volume":"29","author":"Thomas","year":"2021","journal-title":"Mol Ther"},{"key":"10.1053\/j.gastro.2026.04.041_bib32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","article-title":"The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer","volume":"49","author":"Zhang","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2026.04.041_bib33","doi-asserted-by":"crossref","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","article-title":"Immature truncated O-glycophenotype of cancer directly induces oncogenic features","volume":"111","author":"Radhakrishnan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2026.04.041_bib35","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1038\/srep09759","article-title":"Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi\/post-Golgi compartments","volume":"5","author":"Das","year":"2015","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2026.04.041_bib36","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.18632\/oncotarget.3308","article-title":"Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells","volume":"6","author":"Das","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2026.04.041_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026839","article-title":"Pathobiological implications of MUC16 expression in pancreatic cancer","volume":"6","author":"Haridas","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2026.04.041_bib38","doi-asserted-by":"crossref","first-page":"36800","DOI":"10.18632\/oncotarget.9191","article-title":"C-terminus of MUC16 activates Wnt signaling pathway through its interaction with \u03b2-catenin to promote tumorigenesis and metastasis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2026.04.041_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12079-018-0485-z","article-title":"A network map of netrin receptor UNC5B-mediated signaling","volume":"13","author":"Bhat","year":"2019","journal-title":"J Cell Commun Signaling"},{"key":"10.1053\/j.gastro.2026.04.041_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-025-02489-1","article-title":"Netrin-1-UNC5B\/neogenin axis enhances the stemness of colorectal cancer cells","volume":"23","author":"Xia","year":"2025","journal-title":"Cell Commun Signaling"},{"key":"10.1053\/j.gastro.2026.04.041_bib41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1158\/1535-7163.MCT-25-0483","article-title":"Resistance to the KRASG12D inhibitor MRTX1133 is associated with increased sensitivity to BET inhibition","volume":"25","author":"Principe","year":"2026","journal-title":"Mol Cancer Ther"},{"key":"10.1053\/j.gastro.2026.04.041_bib42","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1053\/j.gastro.2026.04.041_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/2159-8290.CD-24-0489","article-title":"Combined KRAS inhibition and immune therapy generates durable complete responses in an autochthonous PDAC model","volume":"15","author":"Liu","year":"2025","journal-title":"Cancer Discov"},{"key":"10.1053\/j.gastro.2026.04.041_bib44","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1038\/onc.2014.409","article-title":"NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer","volume":"34","author":"Kumar","year":"2015","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2026.04.041_bib45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1053\/j.gastro.2026.04.041_bib46","doi-asserted-by":"crossref","first-page":"216150","DOI":"10.1016\/j.canlet.2023.216150","article-title":"Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer","volume":"561","author":"Muilenburg","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1053\/j.gastro.2026.04.041_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.gastro.2026.04.041_bib48","doi-asserted-by":"crossref","first-page":"eadj4698","DOI":"10.1126\/sciadv.adj4698","article-title":"The FLRT3-UNC5B checkpoint pathway inhibits T cell\u2013based cancer immunotherapies","volume":"10","author":"Prajapati","year":"2024","journal-title":"Sci Adv"},{"key":"10.1053\/j.gastro.2026.04.041_bib49","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","article-title":"Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib50","first-page":"119489","article-title":"EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells","volume":"2023","author":"Schumacher","year":"1870","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1053\/j.gastro.2026.04.041_bib51","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1038\/ncomms7072","article-title":"An IL-27\/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction","volume":"6","author":"Zhu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2026.04.041_bib52","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.sjbs.2017.11.006","article-title":"On the significance of Tim-3 expression in pancreatic cancer","volume":"24","author":"Peng","year":"2017","journal-title":"Saudi J Biol Sci"},{"key":"10.1053\/j.gastro.2026.04.041_bib53","article-title":"Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer","volume":"2025","author":"Mahadevan","year":"2025","journal-title":"bioRxiv"},{"key":"10.1053\/j.gastro.2026.04.041_bib54","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ccell.2023.07.002","article-title":"KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells","volume":"41","author":"Mahadevan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2026.04.041_bib55","doi-asserted-by":"crossref","first-page":"e16301","DOI":"10.1200\/JCO.2023.41.16_suppl.e16301","article-title":"Combination of 5-FU plus KRAS G12D inhibitor MRTX1133 against human colorectal and pancreatic cancer cells and the affects on inhibition of pERK and immune-stimulatory cytokine patterns in in KRAS G12D and KRAS G12V tumor cells","volume":"41","author":"Tajiknia","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.gastro.2026.04.041_bib56","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a noncovalent, potent, and selective KRASG12D inhibitor","volume":"65","author":"Wang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1053\/j.gastro.2026.04.041_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42003-021-02934-0","article-title":"Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits","volume":"5","author":"Rodriguez","year":"2022","journal-title":"Commun Biol"},{"key":"10.1053\/j.gastro.2026.04.041_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","article-title":"The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease","volume":"16","author":"Chen","year":"2020","journal-title":"Purinergic Signal"},{"key":"10.1053\/j.gastro.2026.04.041_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000073","article-title":"A long-term study of istradefylline safety and efficacy in patients with Parkinson disease","volume":"38","author":"Kondo","year":"2015","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/j.gastro.2026.04.041_bib60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/14740338.2015.1014798","article-title":"The safety of istradefylline for the treatment of Parkinson\u2019s disease","volume":"14","author":"M\u00fcller","year":"2015","journal-title":"Expert Opin Drug Saf"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526068782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526068782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:11:34Z","timestamp":1793754694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526068782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0016508526068782"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.041","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-rasG12D Inhibition in Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}